These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30762147)

  • 1. Dispensing patterns of selective serotonin reuptake inhibitors before, during and after pregnancy: a 16-year population-based cohort study from the Netherlands.
    Molenaar NM; Lambregtse-van den Berg MP; Bonsel GJ
    Arch Womens Ment Health; 2020 Feb; 23(1):71-79. PubMed ID: 30762147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.
    Bakker MK; Kölling P; van den Berg PB; de Walle HE; de Jong van den Berg LT
    Br J Clin Pharmacol; 2008 Apr; 65(4):600-6. PubMed ID: 17953715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stop or go? Preventive cognitive therapy with guided tapering of antidepressants during pregnancy: study protocol of a pragmatic multicentre non-inferiority randomized controlled trial.
    Molenaar NM; Brouwer ME; Bockting CL; Bonsel GJ; van der Veere CN; Torij HW; Hoogendijk WJ; Duvekot JJ; Burger H; Lambregtse-van den Berg MP
    BMC Psychiatry; 2016 Mar; 16():72. PubMed ID: 26993629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifen.
    Binkhorst L; Mathijssen RH; van Herk-Sukel MP; Bannink M; Jager A; Wiemer EA; van Gelder T
    Breast Cancer Res Treat; 2013 Jun; 139(3):923-9. PubMed ID: 23760858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.
    Grzeskowiak LE; Gilbert AL; Morrison JL
    J Clin Psychopharmacol; 2012 Oct; 32(5):615-21. PubMed ID: 22926594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States.
    Palmsten K; Hernández-Díaz S; Huybrechts KF; Williams PL; Michels KB; Achtyes ED; Mogun H; Setoguchi S
    BMJ; 2013 Aug; 347():f4877. PubMed ID: 23965506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs associated with teratogenic mechanisms. Part I: dispensing rates among pregnant women in the Netherlands, 1998-2009.
    van Gelder MM; Bos JH; Roeleveld N; de Jong-van den Berg LT
    Hum Reprod; 2014 Jan; 29(1):161-7. PubMed ID: 24105826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to and Persistence with Antidepressant Medication during Pregnancy: Does It Differ by the Class of Antidepressant Medication Prescribed?
    Adhikari K; Patten SB; Lee S; Metcalfe A
    Can J Psychiatry; 2019 Mar; 64(3):199-208. PubMed ID: 30252505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and prevalence of primary care antidepressant prescribing in children and young people in England, 1998-2017: A population-based cohort study.
    Jack RH; Hollis C; Coupland C; Morriss R; Knaggs RD; Butler D; Cipriani A; Cortese S; Hippisley-Cox J
    PLoS Med; 2020 Jul; 17(7):e1003215. PubMed ID: 32697803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn.
    Huybrechts KF; Bateman BT; Palmsten K; Desai RJ; Patorno E; Gopalakrishnan C; Levin R; Mogun H; Hernandez-Diaz S
    JAMA; 2015 Jun; 313(21):2142-51. PubMed ID: 26034955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.
    Jordan S; Morris JK; Davies GI; Tucker D; Thayer DS; Luteijn JM; Morgan M; Garne E; Hansen AV; Klungsøyr K; Engeland A; Boyle B; Dolk H
    PLoS One; 2016; 11(12):e0165122. PubMed ID: 27906972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram.
    Mullins CD; Shaya FT; Meng F; Wang J; Harrison D
    Pharmacotherapy; 2005 May; 25(5):660-7. PubMed ID: 15899727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
    Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
    JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of first refill rates among users of sertraline, paroxetine, and citalopram.
    Mullins CD; Shaya FT; Meng F; Wang J; Bron MS
    Clin Ther; 2006 Feb; 28(2):297-305; discussion 296. PubMed ID: 16678651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: A study from The Norwegian Mother and Child Cohort Study.
    Lupattelli A; Wood M; Lapane K; Spigset O; Nordeng H
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1266-1276. PubMed ID: 28815791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postpartum Bleeding in Pregnant Women Receiving SSRIs/SNRIs: New Insights From a Descriptive Observational Study and an Analysis of Data from the FAERS Database.
    Perrotta C; Giordano F; Colombo A; Carnovale C; Castiglioni M; Di Bernardo I; Giorgetti F; Pileri P; Clementi E; Viganò C
    Clin Ther; 2019 Sep; 41(9):1755-1766. PubMed ID: 31371035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy.
    Colvin L; Slack-Smith L; Stanley FJ; Bower C
    Birth Defects Res A Clin Mol Teratol; 2011 Mar; 91(3):142-52. PubMed ID: 21381184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitor prescribing before, during and after pregnancy: a population-based study in six European regions.
    Charlton RA; Jordan S; Pierini A; Garne E; Neville AJ; Hansen AV; Gini R; Thayer D; Tingay K; Puccini A; Bos HJ; Nybo Andersen AM; Sinclair M; Dolk H; de Jong-van den Berg LT
    BJOG; 2015 Jun; 122(7):1010-20. PubMed ID: 25352424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of regulatory advisories on maternal antidepressant prescribing, 1995-2007: an interrupted time series study of 228,876 pregnancies.
    Bobo WV; Epstein RA; Hayes RM; Shelton RC; Hartert TV; Mitchel E; Horner J; Wu P
    Arch Womens Ment Health; 2014 Feb; 17(1):17-26. PubMed ID: 24196827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.